Pharmaceutical firms like Pfizer Inc. are accustomed to having their patents for brand-name drugs challenged by generics makers at the Patent Trial and Appeal Board. But companies that make innovative new drugs may increasingly find challenges coming from another front: other brand companies.
Radio stations must pay royalties to recording companies and composers when their broadcasts are simultaneously streamed over the internet.
Court says Italian electronic group Trucco can formally register "Starix" as an E.U.-wide trademark.
Five of Canada's provinces and territories have software piracy rates in excess of 50%, the Canadian Alliance Against Software Theft says.
Cambria was accused of using Softscape's trade secrets to build its own software and services solutions.
Some experts question validity of patent, but Bluecurrent says it will seek royalties.
Japan's top drug maker sues Mylan Pharmaceuticals, Watson Pharmaceuticals and Ranbaxy Laboratories over their generic versions of ACTOS (pioglitazone HCl).
Patent suit concerned wireless antenna technologies.
Glow Industries had accused Lopez and her partner of infringing its trademark.
Radio operator was accused of unauthorized performance of songs represented by music rights organization.
Shuts down a string of travel-related websites that used names confusingly similar with airlines and travel operators to lure customers.
Defense argues Economic Espionage Act is vague and possibly unconstitutional.
Judge says no "rational" court would find bottles confusingly similar.
Defendants are accused of stealing semiconductor designs and equipment from Silicon Valley companies for China.
Critics claim law would criminalize innocent conduct and extend drug patents another 18 months.
Working group's proposal focuses on preventive measures that can be carried out during the production of disks.
Suit seeks compensation for use of copyrighted domestic tones; foreign music not covered.
Judge sees no sign Disney sought to "somehow poach or free ride" on Caterpillar's trademarks.
Companies had been trading legal volleys for more than one year.
Decision comes in response from corporate concerns about divulging sensitive information in court.
Guidelines call for improved information exchange and training of IPR enforcement personnel.